Medical management of obesity

Surgical Clinics of North America

Volumn 81, Issue 5, 2001, Pages 1025-1038

  Klein, Samuel ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEPRAMONE; BENZPHETAMINE; DOSPAN; MAZINDOL; OBY TRIM; PHENDIMETRAZINE TARTRATE; PHENTERMINE; PHENTERMINE RESIN; PRELU 2; SIBUTRAMINE; TETRAHYDROLIPSTATIN; UNCLASSIFIED DRUG; X TROZINE;

BEHAVIOR MODIFICATION; BODY MASS; DIET THERAPY; ENERGY BALANCE; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; WEIGHT REDUCTION;

EID: 0034834996     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(05)70182-1     Document Type: Article

References (84)

1. Effects of lifestyle activity vs. structured aerobic exercise in obese women: A randomized trial
2. Long-term maintenance of weight loss after a very-low-calorie diet: A randomized blinded trial of the efficacy and tolerability of sibutramine
3. Exercise-training enhances fat-free mass preservation during diet-induced weight loss: A meta-analytical finding
4. Energy density of foods affects energy intake in normal-weight women
5. Inhibition of food intake by inhibitors of fatty acid synthase
6. Sibutramine produces dose-related weight loss
7. Dietary fat intake does affect obesity!
8. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men
9. Weight gain as a risk factor for clinical diabetes mellitus in women
10. A descriptive analysis of men and women who have lost significant weight and are highly successful at maintaining the weight loss
11. A critique of low-carbohydrate ketogenic weight reduction regimens
12. Behavior therapy and pharmacotherapy for obesity
13. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat
14. Metabolic and weight loss effects of long-term dietary intervention in obese subjects
15. The effects of high- and low-energy density diets on satiety, energy intake, and eating time of obese and nonobese subjects
16. One-year treatment of obesity: A randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor
17. Overweight and obesity in the United States: Prevalence and trends, 1960-1994
18. Changes in the distribution of body mass index of adults and children in the US population
19. The metabolic and psychological importance of exercise in weight control
20. Body mass index during childhood, adolescence and young adulthood in relation to adult overweight and adiposity: The Fels Longitudinal Study
21. Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipostatin
22. Temporal trends in energy intake in the United States: An ecologic perspective
23. Long-term maintenance of weight loss following supplemented fasting
24. Orlistat in the long-term treatment of obesity in primary care settings
25. Divergent trends in obesity and fat intake patterns: The American paradox
26. Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: A 1-year study
27. Role of orlistat in the treatment of obese patients with type 2 diabetes
28. Body weight, weight change, and risk for hypertension in women
29. Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweight women
30. Effect of sibutramine on weight maintenance after weight loss: A randomised trial
31. Correlates of weight loss and its maintenance over two years of follow-up among middle-aged men
32. Use of personal trainers and financial incentives to increase exercise in a behavioral weight loss program
33. Long-term weight loss with sibutramine
34. Maintenance and relapse after weight loss in women: Behavioral aspects
35. Long-term effects of varying intensities and formats of physical activity on participation rates, fitness, and lipoproteins in men and women aged 50-65 years
36. Relation of body fat distribution to metabolic complications of obesity
37. A descriptive study of individuals successful at long-term maintenance of substantial weight loss
38. Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men
39. The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: The Swedish Multimorbidity Study
40. Weight, diet, and risk of symptomatic gallstones in middle-aged women
41. Maintenance of successful weight loss: Incidence and prediction
42. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians
43. Efficacy and safety of sibutramine in obese white and African American patients with hypertension: A one-year, double-blind, placebo-controlled, multicenter trial
44. A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients
45. Effect of a low-carbohydrate, high-protein diet on dietary intake
46. Orlistat inhibits dietary cholesterol absorption
47. The long-term effectiveness of combined therapy by behavior modification and very-low-calorie diet: Two year follow-up
48. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - The evidence report
49. Effects of group- versus home-based exercise training in healthy older men and women
50. Effects of four maintenance programs on the long-term management of obesity
51. Maintenance strategies for the treatment of obesity: An evaluation of relapse prevention training and postreatment contact by telephone and mail
52. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indices of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women
53. Obesity in Britain: Gluttony or sloth?
54. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men
55. Determinants of weight gain and overweight in adult Finns
56. Dietary approaches to the treatment of obesity
57. Obesity
58. Weight loss, weight maintenance, and improved cardiovascular risk factors after two years treatment with orlistat for obesity
59. Long-term effects of a very-low -calorie diet (Nutrilett) in obesity treatment. A prospective, randomized comparison between VLCD and a hypocaloric diet plus behavior modification and their combination
60. Randomized evaluation of a low fat 'ad libitum' carbohydrate diet for weight reduction
61. How much physical activity is needed to minimize weight gain in previously obese women?
62. Do obese children become obese adults?
63. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients
64. The effect of covertly manipulating the energy density of mixed diets on ad libitum food intake in "pseudo free-living" humans
65. VLCD plus dietary and behavioral support versus support alone in the treatment of severe obesity: A randomised two-year clinical trial
66. Benefits of lifestyle modification in the pharmacologic treatment of obesity: A randomized trial
67. One-year behavioral treatment of obesity: Comparison of moderate and severe caloric restriction and the effects of weight maintenance therapy
68. Behavioural treatment of the overweight patient
69. A controlled trial of very-low-calorie diet, behavior therapy, and their combination in the treatment of obesity
70. Exercise in the treatment of obesity: Effects of four interventions on body composition, resting energy expenditure, appetite and mood
71. The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men
72. Long-term weight control study V (weeks 190-210): Follow-up of participants after cessation of medication
73. Effects of a very-low-carbohydrate diet program on body weight: A pilot study. Obes Res 8 (suppl Weight, weight change, and coronary heart disease in women: Risk within the 'normal' weight range)
74. Physical activity in the treatment of the adulthood overweight and obesity: Current evidence and research issues
75. Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects
76. Lifestyle intervention in overweight individuals with a family history of diabetes
77. Obesity: Preventing and managing the global epidemic
78. Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: A meta-analysis